Updates ·
Health notices · Monday 26 October
3 notices from the agencies today, in plain words, each with the original linked.
Carolina Infusion tirzepatide injections recalled for sterility concerns
FDA · Recall
If you received tirzepatide injection prepared and supplied by Carolina Infusion LLC, the US Food and Drug Administration reports a Class II recall.
The concern is lack of assurance of sterility, related to formulation using “bacteriostic water” and processing equipment used for the compounded product.
This product was distributed nationwide in the U.S., and the issue was published on 2026-10-14. The notice does not include specific next steps for patients.
Natural Grocers recalls organic mung beans over possible glass
Centers for Disease Control and Prevention (CDC) · Food safety
If you bought Natural Grocers Brand Organic 2-pound mung beans, this recall may affect you.
The concern is foreign material—glass—found as a potential contaminant in the product.
What to do
- Do not eat the recalled mung beans.
- Return the recalled product to the place of purchase for a refund. Then contact Natural Grocers for further instructions.
FDA approves dapagliflozin and metformin extended-release combination for type 2 diabetes
FDA · Approval
If you have type 2 diabetes, the FDA has approved dapagliflozin and metformin hydrochloride extended-release tablets as an add-on to diet and exercise to improve blood sugar control.
Dapagliflozin is an SGLT2 inhibitor (a medicine that helps your body lower blood sugar by affecting kidney processing of glucose). In some people, it also helps lower the risk of certain kidney and heart outcomes described on the label.
If you have type 1 diabetes, the label says these tablets are not recommended for improving blood sugar control. The label also limits use in some kidney conditions and situations involving immunosuppressive therapy.